1. Home
  2. BCAB vs MOGO Comparison

BCAB vs MOGO Comparison

Compare BCAB & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • MOGO
  • Stock Information
  • Founded
  • BCAB 2007
  • MOGO 2003
  • Country
  • BCAB United States
  • MOGO Canada
  • Employees
  • BCAB N/A
  • MOGO N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • MOGO
  • Sector
  • BCAB Health Care
  • MOGO
  • Exchange
  • BCAB Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • BCAB 27.0M
  • MOGO 25.1M
  • IPO Year
  • BCAB 2020
  • MOGO N/A
  • Fundamental
  • Price
  • BCAB $0.47
  • MOGO $1.00
  • Analyst Decision
  • BCAB Buy
  • MOGO Strong Buy
  • Analyst Count
  • BCAB 2
  • MOGO 1
  • Target Price
  • BCAB $1.00
  • MOGO $4.00
  • AVG Volume (30 Days)
  • BCAB 538.8K
  • MOGO 100.0K
  • Earning Date
  • BCAB 05-06-2025
  • MOGO 05-08-2025
  • Dividend Yield
  • BCAB N/A
  • MOGO N/A
  • EPS Growth
  • BCAB N/A
  • MOGO N/A
  • EPS
  • BCAB N/A
  • MOGO N/A
  • Revenue
  • BCAB $11,000,000.00
  • MOGO $28,931,019.00
  • Revenue This Year
  • BCAB N/A
  • MOGO $59.16
  • Revenue Next Year
  • BCAB N/A
  • MOGO $6.17
  • P/E Ratio
  • BCAB N/A
  • MOGO N/A
  • Revenue Growth
  • BCAB N/A
  • MOGO N/A
  • 52 Week Low
  • BCAB $0.24
  • MOGO $0.74
  • 52 Week High
  • BCAB $3.53
  • MOGO $1.95
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 59.13
  • MOGO 52.57
  • Support Level
  • BCAB $0.44
  • MOGO $1.05
  • Resistance Level
  • BCAB $0.58
  • MOGO $1.21
  • Average True Range (ATR)
  • BCAB 0.06
  • MOGO 0.13
  • MACD
  • BCAB 0.00
  • MOGO 0.02
  • Stochastic Oscillator
  • BCAB 64.11
  • MOGO 42.31

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

Share on Social Networks: